1. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction;Lancet,1986
2. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI) GISSI-2: a factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12 490 patients with acute myocardial infarction;Lancet,1990
3. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17 187 cases of suspected acute myocardial infarction: ISIS-2;ISIS-2 (Second International Study of Infarct Survival) Collaborative Group;Lancet,1988
4. Very early thrombolytic therapy in suspected acute myocardial infarction: the Thrombolysis Early in Acute Heart Attack Trial (TEAHAT);The Thrombolysis Early in Acute Heart Attack Trial Study Group;Am J Cardiol,1990
5. The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction;N Engl J Med,1993